TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2024-03-27
吳造中Wu, Chau-Chung
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
r204.cc01@gmail.com
發表文獻
25筆
1
Hsuan CF, Lin FJ, Lee TL, Yang KC, Tseng WK, Wu YW, Yin WH, Yeh HI, Chen JW, Wu CC (Correspondence); Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease. Sci Rep. 2022 Jan 17;12(1):804. doi: 10.1038/s41598-021-04650-5.
2
Pai MC, Wu CC, Hou YC, Jeng JS, Tang SC, Lin WC, Lu CH, Chiu MJ, Chen TF, Yan SH, Hu CJ, Yang SY. Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects. Sci Rep 2022 Jan 24; 12(1): 1192.
3
Wang WT, Wu TC, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Leu HB, Yin WH, Wu CC, Chen JW. Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease. Medicine (Baltimore). 2021 Dec 3;100(48):e27973.
4
Hsuan CF, Lee TL, Tseng WK, Wu CC, Chang CC, Ko TL, Chen YL, Houng JY. Glossogyne tenuifolia Extract Increases Nitric Oxide Production in Human Umbilical Vein Endothelial Cells. Pharmaceuticals (Basel). 2021 Jun 17;14(6):577. doi: 10.3390/ph14060577. PMID: 34204249; PMCID: PMC8235410.
5
Yang YL, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Adherence to healthy lifestyle improved clinical outcomes in coronary artery disease patients after coronary intervention. J Chin Med Assoc. 2021 Jun 1;84(6):596-605. doi: 10.1097/JCMA.0000000000000536. PMID: 33871387.
6
Wang CP, Lu YC, Hung WC, Tsai IT, Chang YH, Hu DW, Hsu CC, Wu CC, Wei CT, Chung FM, Lee YJ. Inter-relationship of risk factors and pathways associated with chronic kidney disease in patients with type 2 diabetes mellitus: a structural equation modelling analysis. Public Health. 2021 Jan;190:135-144. doi: 10.1016/j.puhe.2020.02.007. Epub 2021 Jan 13. PMID: 33451823.
7
Tsai HY, Wu YW, Tseng WK, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Yeh HI, Wu CC, Chen JW; National Taiwan Biosignature Research Investigators. Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions. J Formos Med Assoc. 2021 Jan;120(1 Pt 3):728-736. doi: 10.1016/j.jfma.2020.08.007. Epub 2020 Aug 25. PMID: 32859455.
8
Li YH, Chen JW, Lin TH, Wang YC, Wu CC, Yeh HI, Huang CC, Chang KC, Wu CK, Chen PW, Huang CW, Chen ZC, Chang WT, Huang WC, Wang CY, Lee MY, Chao AC, Fu WR, Tsai LK, Tang SC, Chan HL, Yang YC, Wu YW, Hwang JJ, Lin JL. A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan. J Formos Med Assoc. 2020 Mar;119(3):674-684. doi: 10.1016/j.jfma.2019.04.007. Epub 2019 May 18. PMID: 31113748.
9
Lin CJ, Sun CY, Wu CJ, Wu CC, Wu V, Lin FH. CharXgen-Activated Bamboo Charcoal Encapsulated in Sodium Alginate Microsphere as the Absorbent of Uremic Toxins to Retard Kidney Function Deterioration. Int J Mol Sci. 2020 Feb 13;21(4):1257. doi: 10.3390/ijms21041257. PMID: 32070049; PMCID: PMC7072866.
10
Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. PMID: 32583306.
